Pain Management During COVID-19 and Scope of Ayurvedic Marijuana
DOI:
https://doi.org/10.21467/preprints.104Abstract
During this novel corona virus outbreak, it is found that the most vulnerable population are the old age, especially with co-morbidities like Rheumatoid arthritis (RA) and other related pain diseases that are at greater risk of contracting SARS-CoV-2. This infection is because of their impaired immune systems due to use of corticosteroids and certain drugs. Ayurvedic marijuana, as a safe remedy with phytochemicals known as cannabinoids have shown significant promise in basic experiments on pain management. Study shows leaves?of this plant have been found effective in alleviating pain and other symptoms in patients.
Keywords:
pain management, Ayurvedic marijuana, SARS-CoV-2Downloads
References
Aldrich (1977). Tantric cannabis use in India. Journal of Psychedelic Drugs, Vol. 9(3): 227-233.
Chopra & Chopra (1955). Bulletin on Narcotics (United Nations), vol. 7, No. 3-4.
Favalli et al. (2020). COVID-19 infection and rheumatoid arthritis: Faraway, so close! Autoimmunity Reviews, Volume 19, Issue 5.
https://iiim.res.in/IIIMW/Notifications/CannabisAgreement2020/cannabis.php
Fernando Cervero (2012). Understanding Pain: Exploring the Perception of Pain. Cambridge, Mass.: MIT Press. pp. Chapter 1.
Raj PP (2007). Taxonomy and classification of pain. In: The Handbook of Chronic Pain. Nova Biomedical Books.
Cohen SP & Mao J. (2014). Neuropathic pain: mechanisms and their clinical implications. BMJ; 348: f7656
Breivik et al. (2008). Assessment of pain. British Journal of Anaesthesia, 101 (1): 17–24.
Felson DT. (2008). Osteoarthritis. In: Fauci A, Braunwald E, Kasper D, Hauser S, Longo D, Jameson J, Loscalzo J (Eds). Harrison’s principles of internal medicine, New York, McGraw-Hill, pp 2158–2164.
Yam et al. (2018). General Pathways of Pain Sensation and the Major Neurotransmitters Involved in Pain Regulation, Int. J. Mol. Sci. 19, 2164.
Pacher et al. (2006). The endocannabinoid system as an emerging target of pharmacotherapy, Pharmacol. Rev. 58, 389–462.
Walker et al. (1999). The neurobiology of cannabinoid analgesia, Life Sci. 65, 665–673.
Demuth & Molleman (2006). Cannabinoid signaling, Life Sci, 78, 549–563.
Shoemaker et al. (2005). Agonist-directed trafficking of response by endocannabinoids acting at CB-2 receptors, J. Pharmacol. Exp. Ther. 315, 828–838.
Downloads
Posted
Section
Categories
License
Copyright (c) 2020 Prakash Krishnan, Priya D
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Any non-commercial use, distribution, adaptation, and reproduction in any medium is permitted as long as the original work is properly cited. However, caution and responsibility are required when reusing as the articles on the preprint server are not peer-reviewed. Readers are advised to check for the availability of any updated or peer-reviewed version.
